Skip to main content
Top
Published in: Indian Journal of Gastroenterology 4/2017

01-07-2017 | Original Article

Lymph node micrometastasis in gallbladder cancer

Authors: Swati H. Shah, Nikhil Gupta, Gurudutt Gupta, Anurag Mehta, Shivendra Singh

Published in: Indian Journal of Gastroenterology | Issue 4/2017

Login to get access

Abstract

Background

Prognosis of gallbladder cancer (GBC) is grim even after curative surgery. Lymph node metastasis is the most important prognostic factor, but distant relapses occurring in their absence point towards additional factor. Lymph node micrometastasis could be one. The present study aimed to evaluate the incidence and clinical significance of lymph node micrometastasis.

Methods

This is a prospective study of patients undergoing curative surgery for GBC from 1 March 2013 to 30 April 2015, at our institute. All lymph nodes were examined with hematoxylin and eosin and immunohistochemistry against CK7. The incidence of lymph node and its relation to other clinicopathological parameters, recurrence, and survival was evaluated.

Results

Out of 589 lymph nodes retrieved from 40 patients, metastasis was seen in 13 (2.20%) nodes from 8 (20%) patients and micrometastasis in 4 (0.68%) nodes from 3 (7.5%) patients. Micrometastases were absent in pT1 tumors (0/10 in pT1 vs. 3/30 in pT2–4) and more common in patients with nodal metastasis (13% vs. 6%). Though the presence of micrometastasis would have upstaged the disease, it did not statistically relate to clinicopathological parameters, recurrence, and survival.

Conclusions

Incidence of lymph node micrometastasis in GBC was low and did not correlate with other clinicopathological parameters, recurrence, and survival.
Literature
1.
2.
go back to reference Miura F, Asano T, Amano H, et al. New prognostic factor influencing long-term survival of patients with advanced gallbladder carcinoma. Surgery. 2010;148:271–7.CrossRefPubMed Miura F, Asano T, Amano H, et al. New prognostic factor influencing long-term survival of patients with advanced gallbladder carcinoma. Surgery. 2010;148:271–7.CrossRefPubMed
3.
go back to reference Sasaki E, Nagino M, Ebata T, et al. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with gallbladder carcinoma. Ann Surg. 2006;244:99–105.CrossRefPubMedPubMedCentral Sasaki E, Nagino M, Ebata T, et al. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with gallbladder carcinoma. Ann Surg. 2006;244:99–105.CrossRefPubMedPubMedCentral
4.
go back to reference Jarnagin WR, William R, Ruo L, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003;98:1689–700.CrossRefPubMed Jarnagin WR, William R, Ruo L, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003;98:1689–700.CrossRefPubMed
5.
go back to reference Nagakura S, Shirai Y, Yokoyama N, Hatakeyama K. Clinical significance of lymph node micrometastasis in gallbladder carcinoma. Surgery. 2001;129:704–13.CrossRefPubMed Nagakura S, Shirai Y, Yokoyama N, Hatakeyama K. Clinical significance of lymph node micrometastasis in gallbladder carcinoma. Surgery. 2001;129:704–13.CrossRefPubMed
6.
go back to reference McGuckin M, Cummings M, Walsh M, Hohn B, Bennett J, Wright R. Occult axillary node metastasis in breast cancer: their detection and prognostic significance. Br J Cancer. 1996;73:88–95.CrossRefPubMedPubMedCentral McGuckin M, Cummings M, Walsh M, Hohn B, Bennett J, Wright R. Occult axillary node metastasis in breast cancer: their detection and prognostic significance. Br J Cancer. 1996;73:88–95.CrossRefPubMedPubMedCentral
7.
go back to reference Ishida K, Katsuyama T, Sugiyama A, Kawasaki S. Immunohistochemical evaluation of micrometastasis from gastric carcinomas. Cancer. 1997;79:1069–76.CrossRefPubMed Ishida K, Katsuyama T, Sugiyama A, Kawasaki S. Immunohistochemical evaluation of micrometastasis from gastric carcinomas. Cancer. 1997;79:1069–76.CrossRefPubMed
8.
go back to reference Greenson J, Isenhart M, Rice R, Mojzisik C, Houchens D, Martin E. Identification of occult micrometastasis in pericolic lymph nodes of Dukes’ B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer. 1994;73:563–8.CrossRefPubMed Greenson J, Isenhart M, Rice R, Mojzisik C, Houchens D, Martin E. Identification of occult micrometastasis in pericolic lymph nodes of Dukes’ B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer. 1994;73:563–8.CrossRefPubMed
9.
go back to reference Sasaki M, Watanabe H, Jass J, Ajioka Y, Kobayashi M, Hatakeyama K. Immunoperoxidase staining for cytokeratins 8 and 18 is very sensitive for detection of occult node metastasis of colorectal cancer: a comparison with genetic analysis of K-ras. Histopathology. 1998;32:199–208.CrossRefPubMed Sasaki M, Watanabe H, Jass J, Ajioka Y, Kobayashi M, Hatakeyama K. Immunoperoxidase staining for cytokeratins 8 and 18 is very sensitive for detection of occult node metastasis of colorectal cancer: a comparison with genetic analysis of K-ras. Histopathology. 1998;32:199–208.CrossRefPubMed
10.
go back to reference Sasaki M, Watanabe H, Jass J, Ajioka Y, Kobayashi M, Hatakeyama K. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in “node-negative” colorectal cancer. J Gastroenterol. 1997;32:758–64.CrossRefPubMed Sasaki M, Watanabe H, Jass J, Ajioka Y, Kobayashi M, Hatakeyama K. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in “node-negative” colorectal cancer. J Gastroenterol. 1997;32:758–64.CrossRefPubMed
11.
go back to reference Battifora H. Recent progress in the immunohistochemistry of solid tumors. Semin Diagn Pathol. 1984;1:251–71.PubMed Battifora H. Recent progress in the immunohistochemistry of solid tumors. Semin Diagn Pathol. 1984;1:251–71.PubMed
12.
go back to reference Debus E, Moll R, Franke WW, Weber K, Osborn M. Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. Am J Pathol. 1984;14:121–30. Debus E, Moll R, Franke WW, Weber K, Osborn M. Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. Am J Pathol. 1984;14:121–30.
13.
go back to reference Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982;31:11–24. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982;31:11–24.
14.
go back to reference Copper D, Schermer A, Sun T. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratin: strategies, applications and limitations. Lab Investig. 1985;52:243–56. Copper D, Schermer A, Sun T. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratin: strategies, applications and limitations. Lab Investig. 1985;52:243–56.
15.
go back to reference Tajima Y, Tomioka T, Ikematsu Y, Ichinose K, Inoue K, Kanematsu T. Immunohistochemical demonstration of cytokeratin is useful for detecting micrometastasis foci from gall bladder carcinoma in regional lymph nodes. Jpn J Clin Oncol. 1999;29:425–8.CrossRefPubMed Tajima Y, Tomioka T, Ikematsu Y, Ichinose K, Inoue K, Kanematsu T. Immunohistochemical demonstration of cytokeratin is useful for detecting micrometastasis foci from gall bladder carcinoma in regional lymph nodes. Jpn J Clin Oncol. 1999;29:425–8.CrossRefPubMed
16.
go back to reference Tanabe M, Endo I, Masunari H, et al. Is lymph-node micrometastasis in gallbladder cancer a significant prognostic factor? Hepatogastroenterology. 2012;59:31–5. Tanabe M, Endo I, Masunari H, et al. Is lymph-node micrometastasis in gallbladder cancer a significant prognostic factor? Hepatogastroenterology. 2012;59:31–5.
17.
go back to reference Taniguchi K, Tabata M, Iida T, Hori T, Yagi S, Uemoto S. Significance of lymph node micrometastasis in pN0 hilar bile duct carcinoma. Eur J Surg Oncol. 2006;32:208–12.CrossRefPubMed Taniguchi K, Tabata M, Iida T, Hori T, Yagi S, Uemoto S. Significance of lymph node micrometastasis in pN0 hilar bile duct carcinoma. Eur J Surg Oncol. 2006;32:208–12.CrossRefPubMed
18.
go back to reference Tojima Y, Nagino M, Ebata T, Uesaka K, Kamiya J, Nimura Y. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg. 2003;237:201–7.PubMedPubMedCentral Tojima Y, Nagino M, Ebata T, Uesaka K, Kamiya J, Nimura Y. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg. 2003;237:201–7.PubMedPubMedCentral
19.
go back to reference Ishida K, Katsuyama T, Sugiyama A, Kawasaki S. Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas. Cancer. 1997;79:1069–76.CrossRefPubMed Ishida K, Katsuyama T, Sugiyama A, Kawasaki S. Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas. Cancer. 1997;79:1069–76.CrossRefPubMed
20.
go back to reference Maehara Y, Oshiro T, Endo K, et al. Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence. Surgery. 1996;119:397–402.CrossRefPubMed Maehara Y, Oshiro T, Endo K, et al. Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence. Surgery. 1996;119:397–402.CrossRefPubMed
21.
go back to reference Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr. Identification of occult micrometastases in pericolic lymph nodes of Dukes’ B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer. 1994;73:563–9.CrossRefPubMed Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr. Identification of occult micrometastases in pericolic lymph nodes of Dukes’ B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer. 1994;73:563–9.CrossRefPubMed
22.
go back to reference Yokoyama N, Shirai Y, Hatakeyama K. Immunohistochemical detection of lymph node micrometastasis from gall bladder carcinoma using monoclonal anticytokeratin antibody. Cancer. 1999;85:1465–9.CrossRefPubMed Yokoyama N, Shirai Y, Hatakeyama K. Immunohistochemical detection of lymph node micrometastasis from gall bladder carcinoma using monoclonal anticytokeratin antibody. Cancer. 1999;85:1465–9.CrossRefPubMed
23.
go back to reference Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927–33.CrossRefPubMedPubMedCentral Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927–33.CrossRefPubMedPubMedCentral
24.
go back to reference Liefers GJ, Cleton-Jansen AM, van de Velde CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med. 1998;339:223–38.CrossRefPubMed Liefers GJ, Cleton-Jansen AM, van de Velde CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med. 1998;339:223–38.CrossRefPubMed
25.
go back to reference Koenig AM, Prenzel KL, Bogoevski D, et al. Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma. Ann Surg Oncol. 2009;16:454–62.CrossRefPubMed Koenig AM, Prenzel KL, Bogoevski D, et al. Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma. Ann Surg Oncol. 2009;16:454–62.CrossRefPubMed
26.
go back to reference Ishigami S, Natsugoe S, Tokuda K, et al. Clinical impact of micrometastasis of the lymph node in gastric cancer. Am Surg. 2003;69:573–7.PubMed Ishigami S, Natsugoe S, Tokuda K, et al. Clinical impact of micrometastasis of the lymph node in gastric cancer. Am Surg. 2003;69:573–7.PubMed
27.
go back to reference Yonemori A, Kondo S, Matsuno Y, et al. Prognostic impact of regional lymph node micrometastasis in patients with node-negative biliary cancer. Ann Surg. 2010;252:99–106.CrossRefPubMed Yonemori A, Kondo S, Matsuno Y, et al. Prognostic impact of regional lymph node micrometastasis in patients with node-negative biliary cancer. Ann Surg. 2010;252:99–106.CrossRefPubMed
Metadata
Title
Lymph node micrometastasis in gallbladder cancer
Authors
Swati H. Shah
Nikhil Gupta
Gurudutt Gupta
Anurag Mehta
Shivendra Singh
Publication date
01-07-2017
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 4/2017
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-017-0775-z

Other articles of this Issue 4/2017

Indian Journal of Gastroenterology 4/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.